Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug:58:57-65.
doi: 10.1016/j.ajem.2022.05.022. Epub 2022 May 22.

Acute pain management in the Emergency Department: Use of multimodal and non-opioid analgesic treatment strategies

Affiliations
Review

Acute pain management in the Emergency Department: Use of multimodal and non-opioid analgesic treatment strategies

Megan A Rech et al. Am J Emerg Med. 2022 Aug.

Abstract

Pain is a common complaint precipitating emergency department (ED) visit, occurring in more than half of patient encounters. While opioids are effective for acute pain management in the Emergency Department (ED), the associated adverse effects, including respiratory and central nervous system depression, nausea, vomiting, and constipation, and physical manifestations of use, including tolerance, dependence and misuse leading to overdose and death, accentuate the need for non-opioid alternatives and/or multi-modal pain control. This review will provide examples of non-opioid pain management strategies and multimodal regimens for treatment of acute pain in the ED.

Keywords: Acetaminophen; Acute pain; Dopamine receptor antagonists; Droperidol; Emergency department; Gabapentin; Haloperidol; Ketamine; Lidocaine; Multimodal pain control; Non-steroidal anti-inflammatory drugs; Nonpharmacologic; Opioids; Pregabalin.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no conflicts of interest directly pertaining to this work. Megan Rech, PharmD has investigator-initiated research funding from Spero Pharmaceuticals unrelated to this subject.

MeSH terms

Substances